Anika Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) N/A N/A N/A N/A N/A
    (estimated) €107.86M +4.8% -€281.47K -96.8% -0.3% +0.083 pp €8.25M +36.4% 7.6% +0.018 pp
    (estimated) €102.89M +9.7% -€8.78M -32.7% -8.5% +0.054 pp €6.05M -260.4% 5.9% +0.099 pp
    (estimated) €93.78M -8.3% -€13.05M -72.9% -13.9% +0.33 pp -€3.77M -133.6% -4.0% -0.15 pp
    €102.27M -28.1% -€48.09M -31.8% -47.0% +0.026 pp €11.21M +261.0% 11.0% +0.088 pp
    €142.15M +6.7% -€70.51M +456.3% -49.6% -0.40 pp €3.10M -69.4% 2.2% -0.054 pp
    €133.26M +5.7% -€12.67M -459.4% -9.5% -0.12 pp €10.15M -12.1% 7.6% -0.015 pp
    €126.06M +13.3% €3.53M -117.2% 2.8% +0.21 pp €11.55M -7.8% 9.2% -0.021 pp
    €111.27M +13.8% -€20.46M -188.2% -18.4% -0.42 pp €12.53M -63.1% 11.3% -0.23 pp
    €97.76M +8.6% €23.19M +45.2% 23.7% +0.060 pp €33.97M +0.7% 34.8% -0.027 pp
    €90.03M -6.9% €15.97M -41.2% 17.7% -0.10 pp €33.75M -20.5% 37.5% -0.064 pp
    €96.74M +9.7% €27.14M -2.2% 28.1% -0.034 pp €42.47M +31.7% 43.9% +0.073 pp
    €88.18M +11.2% €27.76M +5.8% 31.5% -0.016 pp €32.25M -21.7% 36.6% -0.15 pp
    €79.32M -11.9% €26.24M -19.7% 33.1% -0.032 pp €41.19M +16.3% 51.9% +0.13 pp
    €90.07M +40.6% €32.68M +86.2% 36.3% +0.089 pp €35.42M +62.2% 39.3% +0.052 pp
    €64.04M +5.2% €17.55M +75.0% 27.4% +0.11 pp €21.84M +112.4% 34.1% +0.17 pp
    €60.87M +10.2% €10.03M +38.9% 16.5% +0.034 pp €10.28M +4.1% 16.9% -0.0097 pp
    €55.25M +16.6% €7.22M +96.2% 13.1% +0.053 pp €9.87M +8.8% 17.9% -0.013 pp
    €47.39M +38.4% €3.68M +17.0% 7.8% -0.014 pp €9.07M +50.8% 19.1% +0.016 pp
    €34.23M +12.2% €3.15M +1.6% 9.2% -0.0096 pp €6.02M -64.1% 17.6% -0.37 pp
    €30.52M +16.1% €3.10M -39.9% 10.1% -0.094 pp €16.76M +2.1% 54.9% -0.075 pp
    €26.30M +14.9% €5.15M +31.1% 19.6% +0.024 pp €16.42M +482.0% 62.4% +0.50 pp
    €22.89M -10.0% €3.93M -21.9% 17.2% -0.026 pp €2.82M -58.9% 12.3% -0.15 pp
    €25.45M +12.7% €5.03M -47.3% 19.8% -0.23 pp €6.87M -66.9% 27.0% -0.65 pp
    €22.57M +71.8% €9.54M +1,253.1% 42.3% +0.37 pp €20.73M +971.3% 91.8% +0.77 pp
    €13.14M +16.8% €705.39K -127.2% 5.4% +0.28 pp €1.93M +438.8% 14.7% +0.12 pp
    €11.25M +16.6% -€2.59M -55.0% -23.1% +0.37 pp €359.05K -112.4% 3.2% +0.33 pp
    €9.65M -30.8% -€5.76M -3,993.7% -59.7% -0.61 pp -€2.91M +147.2% -30.1% -0.22 pp
    €13.93M +21.0% €148.03K -106.9% 1.1% +0.20 pp -€1.18M -155.1% -8.4% -0.27 pp
    €11.51M -2.9% -€2.13M -158.1% -18.5% -0.49 pp €2.13M -55.4% 18.5% -0.22 pp
    €11.86M +15.8% €3.67M +30.3% 30.9% +0.034 pp €4.78M +93.1% 40.3% +0.16 pp
    €10.24M +900.0% €2.81M -222.2% 27.5% +2.5 pp €2.47M -363.6% 24.2% +1.2 pp
    €1.02M -64.7% -€2.30M +35.0% -225.0% -1.7 pp -€938.25K -21.4% -91.7% -0.50 pp
    €2.90M -27.7% -€1.71M +42.9% -58.8% -0.29 pp -€1.19M -36.4% -41.2% +0.056 pp
    €4.01M +113.6% -€1.19M -12.5% -29.8% +0.43 pp -€1.88M -344.4% -46.8% -0.88 pp
    €1.88M -€1.36M -72.7% €767.66K 40.9%

    Notifications